ArticleOncology letters2023

Pretreatment fibrinogen levels are associated with survival outcome in patients with cancer using immunotherapy as a second‑line treatment.

Rui Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.